Thomas Oellerich

5.8k total citations
87 papers, 2.0k citations indexed

About

Thomas Oellerich is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Thomas Oellerich has authored 87 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 27 papers in Hematology and 23 papers in Immunology. Recurrent topics in Thomas Oellerich's work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Thomas Oellerich is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Thomas Oellerich collaborates with scholars based in Germany, United States and United Kingdom. Thomas Oellerich's co-authors include Henning Urlaub, Jürgen Wienands, Hubert Serve, Michael Engelke, Hanibal Bohnenberger, Sebastian Mohr, Konstantin Neumann, He‐Hsuan Hsiao, Facundo D. Batista and Kuan‐Ting Pan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Thomas Oellerich

81 papers receiving 2.0k citations

Peers

Countries citing papers authored by Thomas Oellerich

Since Specialization

Citations

This map shows the geographic impact of Thomas Oellerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Oellerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Oellerich more than expected).

Fields of papers citing papers by Thomas Oellerich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Oellerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Oellerich. The network helps show where Thomas Oellerich may publish in the future.

Co-authorship network of co-authors of Thomas Oellerich

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Oellerich. A scholar is included among the top collaborators of Thomas Oellerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Oellerich. Thomas Oellerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing 2025 ·Leukemia ·Tobias Rausch, (unknown), (unknown), Felix Mölder, (unknown), (unknown), (unknown), Vladimı́r Beneš, Teresa Halbsguth, Uta Brunnberg, Thomas Oellerich, Thomas Tousseyn, Maurilio Ponzoni, (unknown), Martin‐Leo Hansmann, Ralf Küppers, Sylvia Hartmann	0
2	Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patients with stage III unresectable non-small cell lung cancer: A systematic review and meta-analysis 2025 ·European Journal of Cancer ·(unknown), Martin Reck, Daniel Martín, Stefan Rieken, (unknown), (unknown), (unknown), (unknown), Hubert Serve, Thomas Oellerich, Martin Sebastian, Friederike C. Althoff	3
3	RUNX1 interacts with lncRNA SMANTIS to regulate monocytic cell functions 2024 ·Communications Biology ·(unknown), Timothy Warwick, (unknown), Stefan Günther, Sebastian Wolf, (unknown), (unknown), Katalin Pálfi, (unknown), (unknown), (unknown), Stefan Knapp, Andreas Weigert, Rajkumar Savai, Michael A. Rieger, Thomas Oellerich, Ilka Wittig, James A. Oo, Ralf P. Brandes, Matthias S. Leisegang	4
4	Genetic Subclones Reveal Phenotypic Heterogeneity in Diffuse Large B-Cell Lymphoma 2024 ·Blood ·(unknown), George W. Wright, Julius C. Enßle, Yandan Yang, Da Wei Huang, Xin Yu, Arvin Ruiz, James D. Phelan, Arthur L. Shaffer, Thomas Oellerich, Giorgio Inghirami, Louis M. Staudt	0
5	Real‐world effectiveness of first‐line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy 2024 ·European Journal Of Haematology ·(unknown), Jörg Chromik, (unknown), Sebastian Wolf, (unknown), (unknown), Julius C. Enßle, (unknown), Martin Sebastian, Björn Steffen, Thomas Oellerich, Hubert Serve, Andreas Neubauer, Jonas Schäfer, Joerg Thomas Bittenbring	4
6	EZB ‐type diffuse large B‐cell lymphoma cell lines have superior migration capabilities compared to MCD ‐type 2024 ·British Journal of Haematology ·(unknown), (unknown), (unknown), (unknown), (unknown), Andreas Loth, (unknown), Martin‐Leo Hansmann, Thomas Oellerich, Falko Fend, Leticia Quintanilla‐Martinez, Sylvia Hartmann	1
7	Targeting the Sodium–Potassium Pump as a Therapeutic Strategy in Acute Myeloid Leukemia 2024 ·Cancer Research ·Constanze Schneider, (unknown), Gabriela Alexe, Neekesh V. Dharia, (unknown), (unknown), (unknown), Sebastian Scheich, Björn Häupl, Louis M. Staudt, Thomas Oellerich, Kimberly Stegmaier	4
8	Posttranslational Changes in Histone Modification Driven By USP48 Loss Increase Sensitivity to Hypomethylating Agents in Acute Myeloid Leukemia 2024 ·Blood ·Constanze Schneider, Gabriela Alexe, (unknown), (unknown), (unknown), (unknown), (unknown), Yara Rodríguez, Björn Häupl, David E. Root, Thomas Oellerich, Kimberly Stegmaier	1
9	Central nervous system relapse after allogeneic HCT in FLT3-mutated AML 2024 ·Annals of Hematology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fabian Lang, Björn Steffen, Thomas Oellerich, Hubert Serve, Anjali Cremer, Gesine Bug	0
10	The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling 2023 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Tobias Bexte, Evelyn Ullrich, Andreas Loth, Nadine Flinner, Tina Senff, (unknown), Martin‐Leo Hansmann, Matthieu Piel, Björn Häupl, Thomas Oellerich, Emmanuel Donnadieu, Sylvia Hartmann	1
11	Early B cell factor 4 modulates FAS-mediated apoptosis and promotes cytotoxic function in human immune cells 2022 ·Proceedings of the National Academy of Sciences ·Satoshi Kubo, (unknown), Yikun Yao, (unknown), Lixin Zheng, Tovah E. Markowitz, Waipan Chan, Jian Song, Arun K. Boddapati, Keita Saeki, Björn Häupl, Ann Y. Park, Yan Cheng, Jing Cui, Thomas Oellerich, Michael J. Lenardo	10
12	Evaluation and Optimization of High-Field Asymmetric Waveform Ion-Mobility Spectrometry for Multiplexed Quantitative Site-Specific N -Glycoproteomics 2021 ·Analytical Chemistry ·Pan Fang, Yanlong Ji, Ivan Silbern, Rosa Viner, Thomas Oellerich, Kuan‐Ting Pan, Henning Urlaub	18
13	Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression 2020 ·Clinical Cancer Research ·Alison R. Walker, John C. Byrd, James S. Blachly, Bhavana Bhatnagar, Alice S. Mims, Shelley Orwick, Tara L. Lin, Howland E. Crosswell, Danjie Zhang, Mark D. Minden, Veerendra Munugalavadla, Lauren Long, Jinfeng Liu, (unknown), Thomas Oellerich, Hubert Serve, Arati V. Rao, William Blum	27
14	A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics 2020 ·Nature Communications ·Pan Fang, Yanlong Ji, Ivan Silbern, Carmen Doebele, Momchil Ninov, Christof Lenz, Thomas Oellerich, Kuan‐Ting Pan, Henning Urlaub	51
15	Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia 2019 ·Cancer Discovery ·Anjali Cremer, Jana M. Ellegast, Gabriela Alexe, Elizabeth S. Frank, Linda S. Ross, S. Haihua Chu, Yana Pikman, Amanda L. Robichaud, Amy Goodale, Björn Häupl, Sebastian Mohr, Arati V. Rao, Alison R. Walker, James S. Blachly, Federica Piccioni, Scott A. Armstrong, John C. Byrd, Thomas Oellerich, Kimberly Stegmaier	26
16	Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy 2018 ·Blood ·(unknown), Shabnam Shaid, Olesya Vakhrusheva, Sebastian E. Koschade, Kevin Klann, (unknown), (unknown), Jing Zhang, Thomas Oellerich, Duran Sürün, (unknown), Isabella Haberbosch, Stefan Eimer, Heinz D. Osiewacz, Christian Behrends, Christian Münch, Ivan Đikić, Christian Brandts	84
17	Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors 2015 ·Journal of Visualized Experiments ·Hanibal Bohnenberger, (unknown), Sebastian Mohr, (unknown), Tobias Berg, Henning Urlaub, (unknown), Hubert Serve, Thomas Oellerich	1
18	PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation 2014 ·Nature Communications ·Stephan Kolodziej, Olga N. Kuvardina, Thomas Oellerich, Julia Herglotz, Ingo Backert, (unknown), (unknown), Sandra K. Wittmann, Gabriela Salinas-Riester, Halvard Bönig, Michael Karas, Hubert Serve, Ewgenij Proschak, Jörn Lausen	56
19	Fc gamma receptor IIb modulates the molecular Grb2 interaction network in activated B cells 2011 ·Cellular Signalling ·Konstantin Neumann, Thomas Oellerich, (unknown), Henning Urlaub, Michael Engelke	12
20	SLP-65 Phosphorylation Dynamics Reveals a Functional Basis for Signal Integration by Receptor-proximal Adaptor Proteins 2009 ·Molecular & Cellular Proteomics ·Thomas Oellerich, Mads Grønborg, Konstantin Neumann, He‐Hsuan Hsiao, Henning Urlaub, Jürgen Wienands	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact